ClinicalTrials.gov
public full text
Public Domain
An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
Purpose of Study: To examine 1) the short and long-term effectiveness and tolerability of quetiapine (extended release) XR for the treatment of social anxiety disorder (SAD); and 2) continuation effects of quetiapine XR in preventing SAD relapse.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study#847704
- Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients#839006
- Comparative Efficacy and Tolerability of Quetiapine XR and Amitriptyline in the Treatment of Fibromyalgia#993700
- Quetiapine in Co-Morbid Depressive and Anxiety Disorders#993767
- Rhythm and Depression#900959
Record · ID 812226
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive